The DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Developing Guidelines and Competencies for the Training of Psychedelic Therapists
Abstract
Research since the 1950s has shown that psychedelic-assisted psychotherapy has had significant positive effects in reductions of specific clinical symptoms and increases in quality of life as measured on a variety of indices. The intensity of focus on evidence-based outcomes, however, has resulted in a paucity of active discussions and research on the core competencies of the therapists themselves. The context of the history of psychedelic research reveals how this neglect of therapist variables occurred. With current discussions of Phase 3 and expanded access research programs for psilocybin-assisted and MDMA-assisted psychotherapies, there will be a great need for competent therapists trained in this clinical specialty. This is particularly the case if less restricted, legal medical use is approved within the next 6 to 10 years. This article is the first review and compilation of psychedelic therapist competencies derived from the psychedelic literature. These six therapist competencies are empathetic abiding presence; trust enhancement; spiritual intelligence; knowledge of the physical and psychological effects of psychedelics; therapist self-awareness and ethical integrity; and proficiency in complementary techniques. A further contribution of this review is a delineation of the 12 fundamental curricular domains of study for the training and development of these therapist competencies. As current legal restrictions evolve, aspects of these training guidelines will develop accordingly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
null (2016) · Philosophy Study · doi:10.17265/2159-5313/2016.09.003 · Cited by 28,317
Rogers, C. R. (1961) · Cited by 4,342
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 1×
“Griffiths et al. (2016) reported results on a very low dose psilocybin session versus a high-dose psilocybin session for 51 participants with life-threatening cancer.”
BackgroundJournal of Transpersonal Psychology
(1977) · Journal of Humanistic Psychology · doi:10.1177/002216787701700308 · Cited by 1,732
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · cited 1×
“Therapist guides in double-blinded comparison treatment groups need to understand all the nuances and limitations to their behavior in order to keep the integrity of the blind intact through the duration of the study (Griffiths et al., 2006).”
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 3×
“, 2014) and for Heffter, psilocybin for the treatment of anxiety in patients with advancedstage cancer (Grob et al., 2011).”
BackgroundHuman hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
Research works printed but not linked: 48
- Abramson H., 1956, Proceedings of the round table on lysergic acid diethylamide and mescaline in experimental psychiatry, 51
- Abramson H., 1960, Transactions of a conference on LSD
- Badiner A., 2015, Zig zag Zen: Buddhism and psychedelics
- Bonny H. L., 1973, Music and your mind: Listening with a new consciousness
- Buckman J., 1967, The use of LSD in psychotherapy and alcoholism, 83
- Dahlberg C. C., 1967, The use of LSD in psychotherapy and alcoholism, 237
- Danforth A., 2009, Journal of Transpersonal Psychology, 41, 151
- Dass R., 2010, The birth of a psychedelic culture
- Degenhardt L., 2010, The health and psychological effects of ecstasy (MDMA) use
- Doblin R. (2015). From the desk of Rick Doblin: Winter 2015. Retrieved from http://www.maps.org/news/bulletin/articles/392-bulletin-winter-2015/5917-from-the-desk-of-rick-doblin,ph-d-winter-2015
- Doblin R., 2014, Manifesting minds
- Echenhofer F., 2011, A field guide to a new meta-field: Bridging the humanities-neurosciences paradigm, 153
- Emmons R. A., 2003, The psychology of ultimate concerns: Motivation and spiritual in personality
- Epstein M., 1984, Journal of Transpersonal Psychology, 16, 193
- Fischer F., 2015, Therapy with substance: Psycholytic psychotherapy in the twenty-first century
- Fisher G., 1969, Voices, 5, 67
- Grob C., 2002, Hallucinogens: A reader, 263
- Grof S., 1980, LSD psychotherapy
- Grof S., 2005, Higher wisdom: Eminent elders explore the continuing impact of psychedelics, 55
- Grof S., 2009, LSD: Doorway to the numinous
- Grof Transpersonal Training, 2016, Grof Transpersonal Training Application Pack, 19
- 10.17265/2159-5313/2016.09.003 · DOI · Paper page
- Hammer D., 2012, Journal of Allied Health, 41, 49
- Jesse R., 2014, Seeking the sacred with psychoactive substances: Chemical paths to spirituality and to god, 2, 29
- Lennard H., 1960, The use of LSD in psychotherapy, 199
- Maté G., 2010, In the realm of the hungry ghosts
- Metzner R., 2013, The toad and the jaguar
- Metzner R., 2015, Allies for awakening: Guidelines for productive and safe experiences with entheogens
- 10.17265/2159-5313/2016.09.003 · DOI · Paper page
- Naranjo C., 2006, The way of silence and the talking cure
- Naranjo C., 2013, The healing journey
- Narby J., 1998, The cosmic serpent
- Noller G. (2009). Literature review and assessment on MDMA/Ecstasy. Wellington, New Zealand: National Drug Policy, Ministry of Health Publication. Retrieved from http://www.moh.govt.nz/notebook/nbbooks.nsf/0/EE5BDDAA39721D6ACC257B8000708A11/$file/July2010Literature-Review-Assessment-Report-MDMA-Ecstasy.pdf
- Orenda Institute, 2015, Psychedelic psychotherapy training
- Pahnke W. N. (1963). Drugs and mysticism: An analysis of the relationship between psychedelic drugs and the mystical consciousness (Unpublished doctoral thesis). Harvard University, Cambridge, MA.
- Passie T., 2012, Healing with entactogens
- Pollan M., 2015, The New Yorker, 36
- Richards W. A., 2003, Journal of the Association for Music & Imagery, 9, 27
- Richards W. A., 2009, Journal of Transpersonal Psychology, 41, 139
- Stolaroff M., 1997, The secret chief
- Strassman R., 2001, DMT: The spirit molecule
- Strassman R., 2002, Hallucinogens: A reader, 113
- Taylor K., 2007, Considering holotropic breathwork
- Vaughan F., 2001, Psychoactive sacramentals: Essays on entheogens and religion, 191
- Wasson G., 2008, The road to Eleusis: Unveiling the secrets of the mysteries
- Watts A., 1970, The joyous cosmology
- Wolfson P., 2016, The ketamine papers: Science, therapy and transformation
- Young M. (1995). An invitation to entheological dialogue. MAPS Bulletin, 6, 37-38. Retrieved from https://www.maps.org/news-letters/v06n1/06137spi.html
Cited by
Psychiatry & the psychedelic drugs. Past, present & future
Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.040 · Cited by 343
Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression
Murphy, R., Kettner, H., Zeifman, R., Giribaldi, B., Kartner, L., Martell, J., Read, T., Murphy-Beiner, A., Baker-Jones, M., Nutt, D., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.788155 · Cited by 250
“, 2020); and therapist characteristics and qualities (Ackerman and Hilsenroth, 2003; Phelps, 2017).”
BackgroundPsychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Garcia-Romeu, A., & Richards, W. A. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1486289 · Cited by 189
Breeksema, J. J., Kuin, B. W., Kamphuis, J., van den Brink, W., Vermetten, E., & Schoevers, R. A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221116926 · Cited by 178
“Therapist interventions helped resolve this episode by calming this patient down, emphasizing the importance of trained, skilled, and trusting therapists (Mithoefer, et al., 2013a; Phelps, 2017, 2019).”
Background
Metadata
- Authors
- Phelps, J.
- Affiliations
- California Institute of Integral Studies (US)
- Corresponding author
- Phelps, Janis
- Venue
- Journal of Humanistic Psychology
- Publisher
- SAGE Publications
- Published
- 2017-06-29
- Volume
- 57
- Issue
- 5
- Pages
- 450-487
- ISSN
- 0022-1678 (ISSN-L)
- 1552-650X
- OpenAlex
- W2726613221
- Semantic Scholar
- 71db32e01cf8b5521889ca6a4ff012c12e502fda
- Cited by
- 225
- References
- 99
- Citations by year
- 2026: 36 · 2025: 54 · 2024: 43 · 2023: 21 · 2022: 33 · 2021: 23 · 2020: 7 · 2019: 5 · 2018: 2 · 2017: 1
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Humanistic Psychology (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Clinical Psychology › Counseling Practices and Supervision
- Keywords
- psychedelic-assisted psychotherapy, therapist competence, psilocybin-assisted therapy, MDMA-assisted psychotherapy, spiritual intelligence, therapist self-awareness, ethical integrity, complementary techniques, expanded access program
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Developing Guidelines and Competencies for the Training of Psychedelic Therapists. https://app.cochat.ai/papers/10.1177/0022167817711304
- The paper
- Phelps, J. (2017). Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Journal of Humanistic Psychology. https://doi.org/10.1177/0022167817711304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.